Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B. (Q42234793)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

main subject

liver cirrhosis

0 references

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Yao-Chun Hsu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hsien-Yuan Lane

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chi-Yang Chang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chi-Ming Tai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Cheng-Hao Tseng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Gin-Ho Lo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Daw-Shyong Perng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Jaw-Town Lin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Lein-Ray Mo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

26 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

Journal of Antimicrobial Chemotherapy

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1920-1927

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of viral hepatitis and hepatocellular carcinoma

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Metformin--mode of action and clinical implications for diabetes and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Hepatitis D virus: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU041

21 January 2018

Identifiers

DOI

10.1093/JAC/DKU041

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576950%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference